Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012)
Bausch Health Companies (BHC) reported Change in Account Payables of -$9.9 million for Q1 2012, up 73.76% on a YoY basis from -$5.7 million in Q2 2011, and up 35.91% sequentially from -$15.5 million in Q4 2011.
Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Change in Account Payables data on file, last reported at -$9.9 million in Q1 2012.
- For the quarter ending Q1 2012, Change in Account Payables rose 73.76% year-over-year to -$9.9 million; the trailing twelve-month figure through Mar 2012 stood at $18.9 million (up 122.46% YoY), and the FY2011 full-year result was -$9.0 million, up 88.2% from the prior year.
- Change in Account Payables climbed to -$9.9 million in Q1 2012, from -$15.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $34.1 million in Q4 2009 to a low of -$68.1 million in Q4 2010.
- A 4-year average of -$4.0 million and a median of $2.8 million in 2009 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 299.6% in 2010 and jumped 4958.13% in 2011, its largest moves.
- Tracing BHC's Change in Account Payables over 4 years: stood at $34.1 million in 2009, then tumbled by 299.6% to -$68.1 million in 2010, then surged by 77.26% to -$15.5 million in 2011, then surged by 35.91% to -$9.9 million in 2012.
- Business Quant data shows BHC's Change in Account Payables at -$9.9 million in Q1 2012, -$15.5 million in Q4 2011, and $16.8 million in Q3 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | -9.92 Mn |
| Mar 31, 2012 | -9.92 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Jun 30, 2010 | -566,000.00 |
| Jun 30, 2010 | -566,000.00 |
| Mar 31, 2010 | -29.73 Mn |
| Mar 31, 2010 | -29.73 Mn |
| Dec 31, 2009 | 34.11 Mn |
| Dec 31, 2009 | 34.11 Mn |